Zettl UK - Search Results

1

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Trebst C, et al. Among authors: zettl uk. Nat Rev Neurol. 2011 Nov 1;7(12):688-98. doi: 10.1038/nrneurol.2011.176. Nat Rev Neurol. 2011. PMID: 22045269 Review.

2

Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Stangel M, Gold R, Gass A, Haas J, Jung S, Elias W, Zettl UK. Stangel M, et al. Among authors: zettl uk. J Neurol. 2006 Feb;253 Suppl 1:I32-6. doi: 10.1007/s00415-006-1108-9. J Neurol. 2006. PMID: 16477485 No abstract available.

3

A woman with acute myelopathy in pregnancy: case outcome.

Reuss R, Rommer PS, Brück W, Paul F, Bolz M, Jarius S, Boettcher T, Grossmann A, Bock A, Zipp F, Benecke R, Zettl UK. Reuss R, et al. Among authors: zettl uk. BMJ. 2009 Dec 10;339:b4026. doi: 10.1136/bmj.b4026. BMJ. 2009. PMID: 20007656 No abstract available.

4

Immune-mediated CNS diseases: a review on nosological classification and clinical features.

Zettl UK, Stüve O, Patejdl R. Zettl UK, et al. Autoimmun Rev. 2012 Jan;11(3):167-73. doi: 10.1016/j.autrev.2011.05.008. Epub 2011 May 18. Autoimmun Rev. 2012. PMID: 21619943 Review.

5

Rituximab for secondary progressive multiple sclerosis: a case series.

Rommer PS, Patejdl R, Winkelmann A, Benecke R, Zettl UK. Rommer PS, et al. Among authors: zettl uk. CNS Drugs. 2011 Jul;25(7):607-13. doi: 10.2165/11589390-000000000-00000. CNS Drugs. 2011. PMID: 21699272

6

Revised McDonald criteria: the persisting importance of cerebrospinal fluid analysis.

Tumani H, Deisenhammer F, Giovannoni G, Gold R, Hartung HP, Hemmer B, Hohlfeld R, Otto M, Stangel M, Wildemann B, Zettl UK. Tumani H, et al. Among authors: zettl uk. Ann Neurol. 2011 Sep;70(3):520; author reply 521. doi: 10.1002/ana.22508. Epub 2011 Jun 27. Ann Neurol. 2011. PMID: 21710627 No abstract available.

7

Repeated intrathecal triamcinolone acetonide administration in progressive multiple sclerosis: a review.

Abu-Mugheisib M, Benecke R, Zettl UK. Abu-Mugheisib M, et al. Among authors: zettl uk. Mult Scler Int. 2011;2011:219049. doi: 10.1155/2011/219049. Epub 2011 Jun 26. Mult Scler Int. 2011. PMID: 22096630 Free PMC article.

8

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group. Kleiter I, et al. Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216. Arch Neurol. 2012. PMID: 22332191

9

Monoclonal antibodies in the treatment of neuroimmunological diseases.

Rommer PS, Patejdl R, Zettl UK. Rommer PS, et al. Among authors: zettl uk. Curr Pharm Des. 2012;18(29):4498-507. doi: 10.2174/138161212802502125. Curr Pharm Des. 2012. PMID: 22612751 Review.

10

Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration.

Abu-Mugheisib M, Benecke R, Zettl UK. Abu-Mugheisib M, et al. Among authors: zettl uk. Curr Pharm Des. 2012;18(29):4564-9. doi: 10.2174/138161212802502251. Curr Pharm Des. 2012. PMID: 22612755 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page